GlassScriptPhysician profile
Ronaldo D Holgado
NPI 1801849468
$2,276.87
in general payments reported to CMS, 2019-2025
9 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.85 · 2021: $176 · 2022: $158 · 2023: $86.38 · 2024: $1,665 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,199 · Food and Beverage: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,199.43 |
| Food and Beverage | $672.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,541.83 | 2024-2025 | |
| Amgen INC. | $156.71 | 2024 | Krystexxa |
| Horizon Therapeutics Plc | $124.98 | 2022 | |
| Kci USA, INC. | $116.55 | 2021 | |
| Smith+Nephew, INC. | $93.09 | 2019-2025 | Grafix Pl, Stravix Pl |
| Abbvie INC. | $92.78 | 2021-2022 | |
| Orthofix Medical, INC. | $77.39 | 2023-2025 | Physio-Stim, Spinal-Stim |
| Medtronic Vascular, INC. | $52.05 | 2019 | |
| Solventum Corporation | $21.49 | 2025 | Prevena, V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronaldo Holgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.